Waystar Recognized for AI in Healthcare

- The award recognizes Waystar's AltitudeAI™ platform, which utilizes generative AI to autonomously draft appeal letters for denied claims and employs agentic AI to automate revenue cycle workflows with minimal human intervention. - The AI's effectiveness is rooted in a vast proprietary dataset, which includes over 7.5 billion annual healthcare payment transactions and data from one in three U.S. hospital discharges. - Waystar quantifies the platform's impact, stating it has helped clients prevent $15.5 billion in denials, reduce time spent on denial prevention by 95%, and increase the rate of overturned denials by double digits. - The company's AI specifically targets inefficiencies like prior authorizations, a process that can delay patient care and contributes to an estimated $30 billion in annual costs from wrongful denials and errors. - Waystar has aggressively expanded its AI capabilities through acquisitions, notably purchasing Iodine Software for $1.25 billion to integrate clinical intelligence and buying the patient access business of Olive AI, a former AI unicorn that ceased operations. - A 2024 survey conducted with Modern Healthcare found that 75% of healthcare organizations using AI for payment processes reported a positive return on investment, citing benefits like increased staff productivity and reduced operational costs. - The company processes transactions for approximately 60% of the U.S. patient population through its platform, which serves over 30,000 clients and 1 million distinct providers. - Recent analyst coverage highlights Waystar's expanding AI capabilities and end-to-end platform, though the company faces a competitive landscape from other revenue cycle management vendors and potentially larger AI firms expanding into healthcare.